Music to your ears....Dr. Sledge's prediction on her2+ breast cancer

['lizbeth]

Are we talking stage III and IV? Because these numbers do not make sense. The survival statistics for stage I and II was already in the mid to high 90s for 5 years prior to neoadjuvant TCHP.

Is it acceptable that 8 of each 100 women diagnosed will be dead in 3 years?
What if you are one of the eight women? Too bad, so sad?

While I applaud the advances from the TRPHAENA and neoSphere trials, I'm extremely uncomfortable with Dr. Sledge's statements.

However, I'm sure there are other researchers out there who strongly believe in building on the advances in Her2 research and also feel there is no acceptable death rate from cancer.

[michka]

3 years: Ned
4 years: Stage IV.... I hope Dr Sledge doesn't think this is a success.

I have the uncomfortable feeling that with Herceptin, Tykerb, Kadcyla and Pertuzumab many research centers are happy. But we know here that we still need more options.